Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 10, 2008, Pages 1060-1065

  Salama, Joseph K ^a,b   Stenson, Kerstin M ^a   List, Marcy A ^a   Mell, Loren K ^a   MacCracken, Ellen ^a   Cohen, Ezra E ^a   Blair, Elizabeth ^a   Vokes, Everett E ^a   Haraf, Daniel J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC9006 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BARIUM; CARBOPLATIN; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ARTICLE; ASPIRATION; BARIUM MEAL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CONTINUOUS INFUSION; DISEASE SEVERITY; DYSPHAGIA; FLUOROGRAPHY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MOUTH CANCER; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CANCER; OROPHARYNX; OROPHARYNX CANCER; RADIATION DOSE; SCORING SYSTEM; SWALLOWING; TREATMENT OUTCOME; VIDEORECORDING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DEGLUTITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; ODDS RATIO; PROBABILITY; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 54349117948     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.10.1060     Document Type: Article

References (20)

1. Stenson KM, MacCracken E, List M, et al. Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg. 2000;126(3):371-377.
2. Nguyen NP, Moltz CC, Frank C, et al. Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer. Eur J Radiol. 2006;59(3):453-459.
3. Smith RV, Goldman SY, Beitler JJ, Wadler SS. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(7):831-836.
4. Graner DE, Foote RL, Kasperbauer JL, et al. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope. 2003;113(3):573-579.
5. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002;53(1):23-28.
6. Carrara-de Angelis E, Feher O, Barros AP, Nishimoto IN, Kowalski LP. Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg. 2003;129(7):733-738.
7. Logemann JA, Rademaker AW, Pauloski BR, et al. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck. 2006;28(1):64-73.
8. Haraf DJ, Rosen FR, Stenson K, et al. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res. 2003;9(16, pt 1):5936-5943.
9. Logemann JA, Bytell DE. Swallowing disorders in three types of head and neck surgical patients. Cancer. 1979;44(3):1095-1105.
10. Lazarus C, Logemann JA, Gibbons P. Effects of maneuvers on swallowing function in a dysphagic oral cancer patient. Head Neck. 1993;15(5):419-424.
11. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098.
12. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-1944.
13. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945-1952.
14. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21(1):92-98.
15. List MA, Siston A, Haraf D, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 1999;17(3):1020-1028.
16. Fung K, Lyden TH, Lee J, et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys. 2005;63(5):1395-1399.
17. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61(3):772-778.
18. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425-1439.
19. Eisbruch A. Intensity-modulated radiotherapy (IMRT) aiming to reduce dysphagia: early dose-effect correlations. Paper presented at: American Head and Neck Society 2006 Annual Meeting & Research Workshop on the Biology, Prevention, & Treatment of Head & Neck Cancer; August 18, 2006; Chicago, IL.
20. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104(6):1296-1303.